✦ LIBER ✦

Association of epidermal growth factor receptor mutations in lung cancer with chemosensitivity to gefitinib in isolated cancer cells from Japanese patients

✍ Scribed by K. NAKATANI; M. TAKAO; J. NISHIOKA; K. YASUDA; K. NOMA; A. HAYASHI; H. WADA; T. NOBORI

Book ID: 108710425
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 88 KB
Volume: 16
Category: Article
ISSN: 0961-5423
DOI: 10.1111/j.1365-2354.2006.00738.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor gene am

Epidermal growth factor receptor gene amplification and gefitinib sensitivity in patients with recurrent lung cancer

✍ Hidefumi Sasaki; Katsuhiko Endo; Katsuhiro Okuda; Osamu Kawano; Naoto Kitahara; 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 430 KB

Comparative analysis of epidermal growth

Comparative analysis of epidermal growth factor receptor mutations and gene amplification as predictors of gefitinib efficacy in Japanese patients with nonsmall cell lung cancer

✍ Takashi Sone; Kazuo Kasahara; Hideharu Kimura; Kazuto Nishio; Masayuki Mizuguchi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB 👁 1 views

## Abstract ## BACKGROUND. Because the investigation of epidermal growth factor receptor gene (__EGFR__) status as a predictor of gefitinib efficacy in Japanese patients has shown promise, the authors evaluated __EGFR__ mutations and gene amplification in biopsy specimens from Japanese patients wi

The impact of epidermal growth factor re

The impact of epidermal growth factor receptor gene status on gefitinib-treated Japanese patients with non-small-cell lung cancer

✍ Shuji Ichihara; Shinichi Toyooka; Yoshiro Fujiwara; Katsuyuki Hotta; Hisayuki Sh 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 403 KB 👁 2 views

## Abstract We investigated the relationships between genetic factors and clinical outcome in Japanese non‐small‐cell lung cancer (NSCLC) patients treated with gefitinib. Ninety‐eight NSCLC patients who had been treated with gefitinib, were screened for mutations in epidermal growth factor receptor

Simple method to detect important epider

Simple method to detect important epidermal growth factor receptor gene mutations with bronchoscopic specimens of lung cancer patients for gefitinib treatment

✍ Kiwamu Akagi; Hiroshi Sakai; Junko Sudo; Yasuo Hommura; Futoshi Kurimoto; Hirosh 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 189 KB

Epidermal growth factor receptor mutatio

Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer

✍ Jin-Yuan Shih; Chien-Hung Gow; Chong-Jen Yu; Chih-Hsin Yang; Yih-Leong Chang; Me 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 161 KB 👁 2 views

## Abstract Recently, mutations in the __epidermal growth factor receptor__ (__EGFR__) gene in nonsmall cell lung cancer (NSCLC) patients were reported to correlate with gefitinib response. Less than 30% of NSCLC patients are surgically resectable; however, molecular analysis has to rely on nonsurg

Mutations in the epidermal growth factor

Mutations in the epidermal growth factor receptor gene in non-small cell lung cancer: Impact on treatment beyond gefitinib and erlotinib

✍ David F. Heigener; Martin Reck 📂 Article 📅 2010 🏛 Springer Healthcare Communications 🌐 English ⚖ 180 KB